Burt, A.D.

liver patient tacrolimu hepatitis transplantation liver transplantation brosi fi brosis signi ficantly hepatitis c group signi virus transplant hepatic cyclosporine biopsy study ficantly month hepatitis c virus effect progression recipient ishak recurrence hepatic stellate cells transpl infection fi brosis progression hepatitis c infection score result replication disease center fi ndings retrospective inhibitor stellate cirrhosis hepatology difference follow-up liver transplant recipients orthotopic liver transplantation hepatic fi brosis calcineurin analysis immunosuppression graft rejection regimen collagen production tacrolimus group donor calcineurin inhibitors collagen hcv-positive trial therapy survival cyclosporin donor age hepatitis c recurrence c 2 monitoring rejection episodes incidence signi ficant difference liver transplant patients outcome signi ficance watashi k genotype liver transplantation patients table histologic recurrence randomized metselaar hj berenguer